Biobot Surgical

Biobot Surgical is dedicated to revolutionizing robotic-assisted biopsy and treatment for prostate cancer. By leading advancements in prostate cancer management, Biobot Surgical is uniquely positioned to address the global need for a precise approach to transperineal procedures. The company is making a monumental impact on patients' lives through innovative technology.

With its surgical robot, iSR’obot Mona Lisa, Biobot Surgical has achieved significant regulatory milestones, including CE mark (Europe), FDA clearance (US), TGA approval (Australia), and HSA approval (Singapore). This technology is actively utilized in prestigious hospitals worldwide, marking a new era of excellence in prostate disease management. Biobot Surgical is located at 79 Ayer Rajah Crescent, 04-05, Singapore, 139955, SG.

Biobot Surgical remains committed to advancing innovation in robotic-assisted transperineal biopsy and treatment, ensuring that urologists have the precision they require and patients receive the care they deserve. We invite the management team at Biobot Surgical to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.